Bunge Expands Protein and Lecithin Portfolio with IFF Acquisition

Event summary

  • Bunge completed the acquisition of IFF’s soy protein concentrate, lecithin, and soy crush businesses on March 2, 2026.
  • The deal includes IFF’s Response®, Alpha®, Procon®, and Solec™ brands.
  • The acquisition enhances Bunge’s protein and lecithin offerings for food and beverage applications.
  • Brian Douville, VP of emulsifiers and proteins at Bunge, highlighted the transaction’s role in strengthening supply chain resilience.

The big picture

The acquisition aligns with Bunge’s strategy to optimize its ingredients portfolio, addressing the growing demand for plant-based proteins and functional food solutions. This move comes amid broader industry trends of consolidation in the agribusiness sector, as companies seek to strengthen supply chain resilience and meet evolving consumer needs. The deal underscores Bunge’s commitment to diversifying its offerings in the competitive food ingredients market.

What we're watching

Integration Challenges
How Bunge will integrate IFF’s operations and align its workforce with its existing portfolio.
Market Positioning
Whether the acquisition will solidify Bunge’s position as a preferred partner for food and beverage customers.
Product Innovation
The pace at which Bunge leverages the expanded portfolio to develop new high-protein and functional food solutions.

Related topics

Acquisition